Skip to main content
Clinical Trials/NCT02790697
NCT02790697UnknownNot Applicable

Clinical Evaluation of the Ease of Use of a New Indirect Calorimeter for Energy Expenditure Measurement in ICU Patients: The ICALIC International Multicentric Study

University Hospital, Geneva1 site in 1 country30 target enrollmentStarted: September 10, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1
Primary Endpoint
Accuracy of Energy expenditure

Study Overview

Brief Summary

This study aims at validating the accuracy of the new indirect calorimeter (Q-NRG, COSMED, Italy), developed for the ICALIC multicenter study. The validation of accuracy will only be conducted in Geneva center.

The measurements made with the new calorimeter will be compared to the measurements by the mixing chamber method using a mass spectrometer (MAX300-LG, Extrel, USA) for gas composition analysis.

Detailed Description

Indirect calorimetry is a method to measure energy expenditure of human subjects by analyzing patient breath gas to measure the amount (volume) of oxygen consumption (VO2) and CO2 production (VCO2). Energy expenditure is calculated by the Weir's equation using the measured VO2 and VCO2 values.

The new calorimeter is equipped with a disposable in-line pneumotach flowmeter, which measures the flow of exhaled gas of patients directly within the mechanical ventilator circuit. It also samples small amount of inhaled and exhaled gas to measure the inhaled and exhaled O2 and CO2 compositions. The new dynamic micro-mixing chamber technique is used to meaure VO2 and VCO2 to derive the energy expenditure.

The mass spectrometer measures the inhaled and exhaled gas compositions. The mass spectrometer samples inhaled gas from the mechanical ventilator circuit. A mixing chamber system is used to collect the expired gas from the outlet of the mechanical ventilator. The collected gas is measured for the second time after diluting with a constant flow of ambient air, which is monitored by an independent mass flow meter. The volume of the expired gas is calculated by comparison of the concentrations of exhaled gas before and after the dilution. The measurements will be used to calculate the VO2 and VCO2 to derive the energy expenditure.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Mechanically ventilated adult ICU patients

Exclusion Criteria

  • Fraction of inhaled oxygen (FIO2) > 70%
  • Positive end expiratory pressure (PEEP) >10cmH2O
  • Peak ventilatory pressure > 30cmH2O
  • Presence of air leaks from thoracic drain tube
  • Changes in vasoactive agent dose (>20%, <1 hr before and/or during IC)
  • Agitation or change in sedative dose (>20%, <1 hr before and/or during IC)
  • Change in body temperature (>0.5°C, <1 hr before and/or during IC)
  • Expected duration of ICU stay < 24 hours
  • Expected survival of the patient < 24 hours

Outcomes

Primary Outcomes

Accuracy of Energy expenditure

Time Frame: immediately after the measurement

Energy expenditure calculated as a result of VO2 and VCO2 measurements

Secondary Outcomes

  • Respiratory quotient (RQ)(immediately after the measurement)
  • Accuracy of VO2(immediately after the measurement)
  • Accuracy of VCO2(immediately after the measurement)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Claude Pichard

Claude Pichard, MD, PhD

University Hospital, Geneva

Study Sites (1)

Loading locations...

Similar Trials